Betamethasone valerate
Appearance
(Redirected from C27H37FO6)
Clinical data | |
---|---|
Trade names | Betnovate, Celestoderm, Ecoval 70, Hormezon |
Other names | Betamethasone 17-valerate |
AHFS/Drugs.com | Monograph |
Drug class | Corticosteroid; glucocorticoid |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.016.764 |
Chemical and physical data | |
Formula | C27H37FO6 |
Molar mass | 476.585 g·mol−1 |
3D model (JSmol) | |
| |
|
Betamethasone valerate is a synthetic glucocorticoid ester. It is the 17-valerate ester of betamethasone.[2][3] Betamethasone valerate is often used to treat mild eczema with good efficacy and lower incidence of steroid induced adverse effects due to its lower potency compared to other glucocorticoids.[4] Betamethasone-17-valerate is available in cream, ointment, lotion, and foam preparations for topical use.[4][5][6]
See also
[edit]References
[edit]- ^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.
- ^ Ly S, Amici JM (2018). "Role of betamethasone valerate 2.250 mg medicated plaster in the treatment of psoriasis and other dermatological pathologies: a review". Drugs in Context. 7: 212539. doi:10.7573/dic.212539. PMC 6104053. PMID 30151017.
- ^ "Betamethasole valerate". PubChem. U.S. National Library of Medicine.
- ^ a b Raveendran R (November 2019). "Tips and Tricks for Controlling Eczema". Immunology and Allergy Clinics of North America. 39 (4): 521–533. doi:10.1016/j.iac.2019.07.006. PMID 31563186. S2CID 202816063.
- ^ Payne J, Habet KA, Pona A, Feldman SR (August 2019). "A Review of Topical Corticosteroid Foams". Journal of Drugs in Dermatology. 18 (8): 756–770. PMID 31424707.
- ^ Duweb GA, Abuzariba O, Rahim M, al-Taweel M, Abdulla SA (2000). "Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion". International Journal of Clinical Pharmacology Research. 20 (3–4): 65–68. PMID 11314240.